Kelleher Financial Advisors Purchases 43 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kelleher Financial Advisors grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,315 shares of the healthcare conglomerate’s stock after buying an additional 43 shares during the period. UnitedHealth Group makes up 0.6% of Kelleher Financial Advisors’ portfolio, making the stock its 23rd biggest position. Kelleher Financial Advisors’ holdings in UnitedHealth Group were worth $1,677,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. BlackBarn Capital Partners LP lifted its holdings in shares of UnitedHealth Group by 6.7% during the 2nd quarter. BlackBarn Capital Partners LP now owns 32,000 shares of the healthcare conglomerate’s stock valued at $16,296,000 after purchasing an additional 2,000 shares in the last quarter. Insigneo Advisory Services LLC lifted its holdings in shares of UnitedHealth Group by 9.0% during the 2nd quarter. Insigneo Advisory Services LLC now owns 10,890 shares of the healthcare conglomerate’s stock valued at $5,546,000 after purchasing an additional 897 shares in the last quarter. Lone Pine Capital LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $480,903,000. Fred Alger Management LLC raised its position in UnitedHealth Group by 16.7% in the 2nd quarter. Fred Alger Management LLC now owns 103,957 shares of the healthcare conglomerate’s stock valued at $52,941,000 after buying an additional 14,880 shares during the last quarter. Finally, Point72 Hong Kong Ltd raised its position in UnitedHealth Group by 11.2% in the 2nd quarter. Point72 Hong Kong Ltd now owns 22,069 shares of the healthcare conglomerate’s stock valued at $11,239,000 after buying an additional 2,221 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Trading Down 1.1 %

Shares of UNH stock opened at $519.08 on Thursday. The company has a market cap of $477.70 billion, a P/E ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62. The stock has a 50 day simple moving average of $545.26 and a two-hundred day simple moving average of $564.10. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.